AE1/AE3, Vimentin and p63 immunolocalization in canine mammary gland tumours: Roles in differentiation between luminal epithelial and myoepithelial lineages

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 1, 2010, Pages 227-230

  Toniti, P ^a   Sirivisoot, S ^a   Jandee, P ^a   Srimontri, P ^a   Puchadapirom, P ^b   Doungchawee, G ^b   Kasorndorkbua, C ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Kasetsart University ^*  (Thailand)

^c KASETSART UNIVERSITY   (Thailand)

Author keywords

Canine mammary tumors; Luminal epithelial; Marker immunohistochemistry; Myoepithelial

Indexed keywords

ANTIPORTER; MEMBRANE PROTEIN; VIMENTIN;

ANIMAL; CELL LINEAGE; DOG; DOG DISEASE; ENZYME IMMUNOASSAY; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; METABOLISM; MYOEPITHELIOMA; NEOPLASM; PATHOLOGY; VETERINARY;

ANIMALS; ANTIPORTERS; CELL LINEAGE; DOG DISEASES; DOGS; FEMALE; IMMUNOENZYME TECHNIQUES; MAMMARY NEOPLASMS, ANIMAL; MEMBRANE PROTEINS; MYOEPITHELIOMA; NEOPLASMS, GLANDULAR AND EPITHELIAL; VIMENTIN;

EID: 77955790577     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Allred CD, Harvey JM, Berardo M, et al (1998). Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol, 11, 155-68.
2. Batistatou A, Stefanou D, Arkoumani E, Agnantis NJ (2003). The usefulness of p63 as a marker of breast myoepithelial cells. In vivo, 17, 573-6.
3. Bonnie LK (2002). Immunohistochemical analysis of breast cells obtained by ductal lavage. Cancer Cytopathol, 96, 244-9.
4. Brunetti B, Sarli G, Marcato PS, Benazzi C (2003). Histochemical and immunohistochemical characterization of canine mammary mucinous carcinoma. J Comp Path, 129, 131-6.
5. Bussolati G, Gugliotta P, Morra I, Pietribiasi F, Berardengo E (1986). The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast. Br J Cancer. 54. 631-636.
6. Destexhe E, Lespagnard L, Degeyter M, Heymann R, and Coignoul F (1993). Immunohistochemical identification of myoepithelial, epithelial, and connective tissue cells in canine mammary tumors. Vet Pathol, 30, 146-54.
7. Espinosa De Los Monteros A, Millán MY, Ordás J, et al (2002). Immunolocalization of the smooth muscle-specific protein Calponin in complex and mixed tumors of the mammary gland of the dog: assessment of the morphogenetic role of the myoepithelium. Vet Pathol, 39, 247-56.
8. Foschini MP, Eusebi V (1998). Carcinomas of the breast showing myoepithelial cell differentiation. A review of the literature. Virchows Arch, 432, 303-10.
9. Gama A, Alves A, Gartner F, Schmitt F (2003). p63: A novel myoepithelial cell markers in canine mammary tissues. Vet Pathol, 40, 412-20.
10. Gärtner F, Geraldes M, Cassali G (1999). DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed mammary tumors: putative evidence for a common histogenesis. Veterinary J, 158, 39-47.
11. Griffey SM, Madewell BR, Dairkee SH, et al (1993). Immunohistochemical reactivity of basal and luminal epithelium-specific cytokeratin antibodies within normal and neoplastic canine mammary glands. Vet Pathol, 30, 155-61.
12. Lakhani SL, O'Hare MJ (2001). The mammary myoepithelial cell - Cinderella or ugly sister. Breast Cancer Res, 3, 1-4.
13. MacEwan EG, Harvey HJ, Patnaik AK, et al (1985) Evaluation of effects of levamisole and surgery on canine mammary cancer. J Biol Resp Mod, 4, 418-26.
14. Morrison WB (2002). Cancers in Dogs and Cats - Medical and Surgical Management (2nd ed.). Wyoming: Teton NewMedia.
15. Moulton JE (1990). Tumors of the mammary gland. In: Tumors in Domestic Animals (3rd ed.). California: University of California Press.
16. Novosad CA (2003). Principles of treatment for mammary gland tumors. Clinical Techniques Small Animal Practice, 18, 107-9.
17. Rabanal RM, Else RW (1994). Immunohistochemical localisation of cytokeratin and vimentin intermediate filament proteins in canine mammary tumours. Res Vet Sci, 56, 225-33.
18. Rutterman GR, Withrow SJ, MacEwan EG (2001).Tumors of the mammary gland, in Withrow SJ, MacEwan EG (eds): Small Animal Clinical Oncology (3rd ed.) Philadelphia: WB Saunders Co.
19. Sartin E, Barnes S, Toivio-Kinnucan M, et al (1993). Heterogenic properties of clonal cell lines derived from canine mammary carcinomas and sensitivity to tamoxifen and doxorubicin. Anticancer Res, 13, 229-36.
20. Schneider R, Dorn CR, Taylor DON (1969). Factors influencing canine mammary cancer development and postsurgical survival. J Natl Cancer Inst, 43, 1249-61.
21. Sorenmo K, Shofer FS, and Goldschmidt MH (2000). Effect of spaying and timing of sapying on survival of dogs with mammary carcinoma. J Vet Int Med, 14, 266-70.
22. Sorenmo K (2003). Canine mammary gland tumors. Vet Clin North Am Small Anim Pract, 33, 573-96.
23. Stratmann N, Failing K, Ritchter A, and Wehrend A (2008). Mammary tumor recurrence in bitches after regional masectomy. Veterinary Surg, 37, 82-6.
24. Veerle F (2005). Immunohistochemical Study of Canine Mammary Gland Tumors. Uppsala University.
25. Vos JH, van den Ingh TS, Misdorp W, et al (1993a). Immunohistochemistry with keratin, vimentin, desmin, and alpha-smooth muscle actin monoclonal antibodies in canine mammary gland: benign mammary tumours and duct ectasias. Vet Q, 15, 89-95.
26. Vos JH, van den Ingh TS, Misdorp W, et al (1993b). Immunohistochemistry with keratin, vimentin, desmin, and alpha-smooth muscle actin monoclonal antibodies in canine mammary gland: malignant mammary tumours. Vet Q, 15, 96-102.
27. Vos JH, van den Ingh TS, Misdorp W, et al (1993c). Immunohistochemistry with keratin, vimentin, desmin, and alpha-smooth muscle actin monoclonal antibodies in canine mammary gland: normal mammary tissues. Vet Q, 15, 102-107.
28. Zuccari DA, Santana AE, Rocha NS (2002). Expression of intermediate filaments in canine mammary tumor diagnosis. Arq Bras Med Vet Zootec, 54, 586-91.